Book your place at Annual Conference

The leading rheumatology event, bringing together over 2,000 delegates for three days of learning, knowledge sharing, networking and innovation.

Biosimilar adalimumab is a test of shared decision-making in the NHS

The entry of new biosimilars and the creation of an NHS ‘local market of treatment options’ across England is likely to see a number of patients switched from the originator product, Humira, to one of four biosimilar alternatives this year.

Careers in rheumatology

Rheumatologist

Here's what you need to become a adult or paediatric and adolescent rheumatologist Find out more

Nurse

Here's what you need to become an adult or paediatric and adolescent Rheumatology Specialist Nurse Find out more

Physiotherapist

Here's what you need to become a physiotherapist specialising in rheumatology Find out more

Podiatrist

Here's what you need to become a podiatrist specialising in rheumatology Find out more

Occupational therapist

Here's what you need to become an occupational therapist specialising in rheumatology Find out more

Pharmacist

Here's what you need to become a pharmacist specialising in rheumatology Find out more

Academic

Here's what you need to become an academic researcher specialising in rheumatology Find out more

Upcoming events